Company Filing History:
Years Active: 2017
Title: Frank Diehl: Innovator in Genetic Mutation Detection
Introduction
Frank Diehl is a prominent inventor based in Hamburg, Germany. He has made significant contributions to the field of genetic research, particularly in the detection of oncogenic mutations. With a total of 2 patents, Diehl's work has the potential to impact cancer diagnostics and treatment.
Latest Patents
Diehl's latest patents include innovative methods for detecting oncogenic mutations. These methods focus on the detection of genetic mutations associated with cancer, specifically in the KIT gene. Another notable patent involves emulsion systems and emulsion-based amplification of nucleic acid. This patent provides methods for efficient and high-throughput emulsion-based nucleic amplification, requiring minimal input energy to form effective emulsions for nucleic acid amplification.
Career Highlights
Frank Diehl is currently associated with Sysmex Corporation, where he continues to advance his research in genetic mutation detection. His work is characterized by a commitment to improving diagnostic methods that can lead to better patient outcomes.
Collaborations
Diehl has collaborated with notable colleagues, including Johannes Fredebohm and Frank Holtrup. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Frank Diehl's contributions to genetic research and cancer diagnostics are noteworthy. His patents reflect a dedication to advancing medical technology and improving the lives of patients.